HealthQuill Supply chain disruptions
There is a shortage of prescription stimulant medications in the US due to a manufacturing delay by one drugmaker last fall that had a cascading effect on supplies, according to the FDA and DEA.
Drugs Health Pharma

Dearth of stimulant drugs hit US, FDA, DEA calls for offloading quotas

HQ Team August 2, 2023: There is a shortage of prescription stimulant medications in the US due to a manufacturing delay by one.

Read More
Glenmark Pharmaceuticals, an Indian global drug maker with a focus on dermatology, respiratory and oncology areas, forecasts lifting of China's COVID-19 curbs may ease disruptions in the supply chain situation.
Drugs Medical Pharma

China’s lifting of COVID-19 curbs to ease supply chain disruptions: Glenmark

Glenmark Pharmaceuticals, an Indian global drug maker with a focus on dermatology, respiratory and oncology areas, forecasts lifting of China's COVID-19 curbs may.

Read More
X